Editor-in-Chief of OBM Geriatrics

Calogero CarusoCalogero Caruso, formerly Full Professor of General Pathology, is Professor Emeritus at the University of Palermo, Italy. He graduated from the School of Medicine, University of Palermo, Italy, in 1971 (magna cum laude). He was founder and editor-in-chief of the journal Immunity & Ageing (2004-2018), and, as of November 2021, he is the author of 391 publications (14,146 citations), mainly on aging, diseases related to age and longevity, immunosenescence and immunopathology, indexed on Scopus (H index of 62). He has recently edited the book “Centenarians. An example of positive biology.” for Springer Nature and, with Prof. Giuseppina Candore, the book “Human Aging. From Cellular Mechanisms to Therapeutic Strategies”. He was national coordinator of Italian Ministerial Project on Centenarians and Longevity (2017-2020). He was Coordinator of the PhD program in Molecular Medicine and Biotechnology (formerly Pathobiology) (1998-2018). The national and international recognition of his scientific achievements in the field of Biogerontology is documented by funded projects, by the number of citations of his papers, by invitations to national and international congresses and meetings, by his activity as a project reviewer and by organization of international conferences.

Section Editor-in-Chief of Advances in Chemical Research

Suni Professor Zhe-Sheng (Jason) Chen obtained a doctorate (Ph.D.) in Pharmacology from Kagoshima University, Japan. Dr. Chen also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master’s degree in Toxicology from Sun Yat-Sen Medical University, China. Currently Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. Dr. Chen is also the Director of Institute for Biotechnology at St. John’s University. He has published more than 200 scientific publications. Dr. Chen is the founding Editor-in-Chief for Journal of Cancer Research Updates and is also the Editor-in-Chief for Recent Patents on Anti-Cancer Drug Discovery and Journal of New Developments in Chemistry, as well as an editor of African Journal of Pharmacy and Pharmacology. He is an editorial board member of 26 journals and a reviewer of more than 250 peer-reviewed journals. As a consultant to pharmaceutical, biotechnology and health industry organizations, Dr. Chen commands invitations for more than 290 presentations, keynote addresses, and conference chairman. Dr. Chen is also a grant reviewer for the National Institutes of Health (NIH, USA), Chinese National Natural Science Foundation (China), the Genesis Oncology Trust (New Zealand), National Science Centre (Poland), the Government of the Hong Kong Special Administrative Region (HKSAR) Grant (Hong Kong, China), the Hungarian Scientific Research Fund (OTKA) (Hungary), the Netherlands Organisation for Scientific Research (NWO) (Netherlands), and the Czech Science Foundation (Czech).

Section Editor-in-Chief of Advances in Chemical Research

Suni Professor Narayan S. Hosmane obtained a Ph.D. degree in Inorganic Chemistry from the University of Edinburgh, Scotland. Prof. Hosmane is currently a Distinguished Research Professor of Chemistry and Biochemistry and an Inaugural Board of Trustees Professor at Northern Illinois University, DeKalb. He received the coveted Humboldt Research Award for senior scientists twice. This award is presented annually, by Alexander von Humboldt Foundation, Bonn, Germany, to scientists worldwide as a tribute to their lifelong accomplishments. He was the founder of Boron in the Americas (formerly known as BUSA) and hosted the organization's first meeting in Dallas in April 1988. He has published over 300 papers in leading scientific journals and was ranked by the Institute for Scientific Information (ISI) in the top 50 percent of the most cited chemists in the world from 1981–1997. In September 2007, at the launch of the NRI Institute's Washington D.C. chapter, the NRI Institute presented him with its Pride of India Gold Award, in recognition of his outstanding accomplishments. That following January, he was honored by the same NRI Institute with its Lifetime Achievement Pravasi Award and Bharath Samman Medal during the Annual Conference held in New Delhi, India. A fellow of the Royal Society of Chemistry and the American Institute of Chemists, he has also been listed in Who's Who in the World. In June 2018, Narayan Hosmane was honored with a Special Dedicated Issue of Journal of Organometallic Chemistry, published by the Elsevier Science.

Editor-in-Chief of Journal of Energy and Power Technology

Zhao Yang DongZhao Yang Dong (M’99–SM’06-F'17) obtained Ph.D. degree from the University of Sydney, Australia in 1999. He is currently the SHARP professor and Director of the University of New South Wales Digital Grid Futures Institute, The University of New South Wales, Australia. He is also Director for ARC Research Hub for Integrated Energy Storage Solutions. He was previously Professor and Head of School of Electrical and Information Engineering, University of Sydney, and Ausgrid Chair and Director of the Ausgrid Centre for Intelligent Electricity Networks, the University of Newcastle, Australia. He also held industrial positions with Transend Networks (now TAS Networks), Australia. His research interests include smart grid, power system planning, power system security, renewable energy systems, electricity market, load modelling, and computational intelligence and its application in power engineering. He is serving/served as an editor of IEEE Transactions on Smart Grid, IEEE Power Engineering Letters, and IET Renewable Power Generation.HE is Fellow of IEEE.

Zhao Yang DongAssociate Editor of Journal of Energy and Power Technology


Dr IMR Fattah is a Research Fellow in the School of Civil and Environmental Engineering, Faculty of Engineering and IT at the University of Technology Sydney, where he is researching the effective use of waste for sustainable energy applications. His research interests stem from the PhD in the combustion of renewable fuels he completed at the University of New South Wales in 2019, where he focused on the reduction of emissions (particularly PM/soot) from diesel combustion. Dr IMR Fattah was named one of the Top 2% of Scientists in the World in 2021 by Elsevier BV and Stanford University. He is actively engaged in the field by editing four books, publishing 3 book chapters, over 90 international publications in prestigious international journals. He is serving as an 'Associate Editor' at editorial boards of multiple prestigious journals. He is managing/has managed ten topical/special issues as 'Guest Editor'. He has also peer-reviewed over 275 journal articles throughout his career. Dr IMR Fattah would like to remain at the forefront of research in the field of renewable and sustainable energy.

Editor-in-Chief of OBM Neurobiology

Bart EllenbroekBart Ellenbroek received his PhD from the Radboud University in Nijmegen, the Netherlands, where he stayed as assistant and associate Professor until 2006. That year he moved to a biotech company in Hamburg, Germany where he was vice president of neuropharmacology until 2011, when he moved to the other side of the world, to New Zealand. He is currently Professor and deputy head of School at Victoria University of Wellington.

In Wellington, Bart leads the Behavioural Neurogenetics group at the school of psychology, which focusses on gene-environment interactions in psychiatry, using several genetic rat models. Although the main emphasis of their work is on behaviour, the research also involves recording ultrasonic vocalizations and physiological parameters such as heart rate and body temperature. The central research theme allows for a broad range of topics to be investigated, and within the group, students are working on schizophrenia, depression, autism spectrum disorders and drug addiction. For more information see

Section Editor-in-Chief of OBM Neurobiology

Najam SharifNajam Sharif, PhD, DSc has >34-years’ pharmaceutical drug discovery research/development experience covering Neuroscience and Ophthalmology. His 22-year tenure at Alcon resulted in his contributions to the discovery, characterization, development and US FDA approvals of Patanol®/Pataday®/Pazeo® and Emadine® to treat allergic conjunctivitis, and Travatan® and Simbrinza® for the treatment of ocular hypertension / Glaucoma. Currently, he is Vice President, Global Alliances and External Research, Ophthalmology Innovation Center at Santen Inc USA, where he has been instrumental in establishing, nurturing and managing long term partnerships with pharma companies and collaborations with several global universities. Dr. Sharif  serves on numerous committees of many  learned Societies (including ISER, elected Trustee of AOPT & Gold Fellow; Gold Fellow of ARVO and Fellow of British Pharmacological Society (BPS)).  Dr. Sharif is Editorial Board member of many Pharmacology, Neuroscience and Ophthalmic journals.  He also serves on the Board of Directors and the Scientific Advisory Board of The Glaucoma Foundation. He is the recipient of the inaugural “Dr. Roger Vogel Award” for ocular pharmaceutical research (ARVO Foundation, 2014), the recipient of the “Sir James Black Award” for contributions to drug discovery (BPS, 2017), and awardee of the “Ernst H. Barany Prize” for outstanding contributions to ocular pharmacology (2020). Dr. Sharif is an Adjunct Professor / Honorary Senior Lecturer / Senior Principal Investigator and Graduate Faculty at multiple Universities worldwide. He has also been a PhD-candidates’ supervisor, advisor and mentor to several students at numerous academic institutions. Dr. Sharif has published >215 scientific articles, edited 3 books, holds 24 issued US/EU patents, and has filed additional >30 patent applications over the last two decades.

Editor-in-Chief of OBM Genetics

Suni Joep Geraedts (1948) obtained a BSc (1969) and MSc (1972) in general biology at the University of Nijmegen. At Leiden University he defended his PhD thesis in 1975. From 1982 to 2013 he was professor of Genetics and Cell Biology at Maastricht University and head of the Department of Clinical Genetics of the University Hospital. In 1995 he started the first and only licensed PGD programme in the Netherlands. He was chairman of the Dutch Society of Human Genetics (1984-1988); chairman of the Dutch Association of Clinical Genetics Centers (2000-2013), chairman of the European Society of Human Reproduction and Embryology (2007-2009) and member of the Dutch Health Council.

Associate Editor-in-Chief OBM Genetics


Bruce O’Hara received his PhD in Human and Mammalian Genetics from The Johns Hopkins University School of Medicine in 1988, where he studied mouse models of trisomy 21 (Down Syndrome), comparative genomics, and developmental neurobiology. He then did postdoctoral work at NIDA/NIH investigating genes involved in various drug responses and genetic predisposition to substance use disorders. He next spent twelve years at the Stanford University Center for Sleep and Circadian Neurobiology where he established a research program directed towards an understanding of sleep using higher throughput behavioral and genomic methodologies. He then joined the faculty at the University of Kentucky, Dept. of Biology in 2003. He currently has over 35 years of experience in mammalian genetics and especially mouse models of human disease, and has over 95 publications in areas ranging from the effects of drugs to large-scale genetic screens and models of neurodegenerative disorders. Most of these studies utilize the piezoelectric sleep-wake monitoring system developed by O’Hara and colleagues at Stanford and the University of Kentucky, and later commercialized by Signal Solutions in 2009. This technology is now used in laboratories across the world.

Editor-in-Chief of Catalysis Research

Jennifer KeoghProfessor Roger Gläser received his Ph.D. degree in Chemistry from the University of Stuttgart in 1997. After a research stay at the School of Chemical Engineering of Georgia Institute of Technology, Atlanta, USA, he returned to the University of Stuttgart and completed his habilitation in Chemical Technology in January 2007. Since August 2007, he is a Full Professor of Chemical Technology and the Director of the Institute of Chemical Technology at Leipzig University. His research interests include the preparation and characterization of novel sorbents and catalysts with defined nanoporosity, aftertreatment of diesel off-gas by SCR-based technologies, the utilization of renewable resources, photocatalysis and diffusion in heterogeneous catalysis. He currently serves as dean of his faculty, head of the commission of the German Catalysis Society and head of the German Zeolite Association.

Editor-in-Chief of Recent Progress in Materials

HosseinkhaniDr. Hossein Hosseinkhani, Biomedical Engineer, has broad experience in life sciences and is an expert in nanotechnology, biomaterials, drug delivery, 3D in vitro systems, bioreactor technology, and bioengineering stem cells technology. His working experience is mainly attributed to academia and industry of biomedical engineering research and development (which includes several years of basic science research experience in a number of premier institutions related to the structure and function of biomaterials, and in polymer-based and mineral-based medical implants development in the medical device industry). He has been awarded several prestigious awards including JSPS (Japan Society for Promotion of Science) of Japan, European Marie Skłodowska-Curie Award, and Japanese ICYS (International Center for Young Scientists) Award. He authored more than 100 scientific papers published on peer-reviewed Journals, 5 books, and 10 book chapters (H-index: 46 Google Scholar). He is inventor of 16 National and International patents, several of which are licensed to companies acting in the biomedical fields and translated to 7 commercial products. He is the founder of Matrix HT, Inc., a world leading Biotech Company dedicated to healthcare technology to improve patient's quality of life. He is Editor-in-Chief of Recent Progress in Materials, a peer-reviewed Open Access journal published online by LIDSEN Publishing Inc., and Editor-in-Chief of Journal of Modern Nanotechnology, a peer-reviewed Open Access journal published online by the Innovation Forever Publishing Group Limited. Dr. Hosseinkhani also has been selected as the Country Editor of Current Drug Delivery.

Editor-in-Chief of Recent Progress in Nutrition

Jennifer KeoghDr Keogh was awarded a Doctor of Philosophy (Ph.D.) from the University of Adelaide Australia for a thesis entitled “Nutrition and Vascular Health”. She holds a Master of Science (MSc) degree from the University of Melbourne, Australia for a thesis entitled Bone Mass and Body Composition in Adults: Effects of Liver Transplantation. Dr Keogh is Associate Professor of Dietetics and Nutrition at the University of South Australia (2010). She qualified as a dietitian from the College of Technology Dublin which is now the Technological University Dublin where she holds the title of Adjunct Professor. Dr Keogh was awarded a Fellowship of the South Australian Cardiovascular Research Development Program funded by the Heart Foundation and the Government of South Australia, March 2013 - March 2016. She also received The Commonwealth Scientific and Industrial Research Organisation’s Medal for Research Excellence in 2005. She is a member of the University of South Australia’s Alliance for Research in Exercise, Nutrition and Activity Research Centre. Dr Keogh had a career in clinical dietetics and held leadership positions at the Hammersmith and Queen Charlotte’s Special Health Authority in London, St. James Hospital London, the Royal Hobart Hospital, Tasmania, Australia and Ballarat Health Services, Victoria, Australia. She has a substantial scientific output with 150 peer reviewed publications to date, an h-index of 44 and 5934 citations (Scopus 2021).

Editor-in-Chief of OBM Integrative and Complementary Medicine

SuniGerhard Litscher obtained M.Sc. (Biomedical Engineering, 1984) and Ph.D. (Doctor of Technical Sciences, 1987) from Graz University of Technology, and (Doctor of Medical Sciences, 2004) from Medical University of Graz, Austria. He has been leader or member of international professional societies, e.g., President of International Society for Medical Laser Applications (2012 to date); President of European Medical Laser Association-Austria (2012-2013); Vice president of International Medical Laser Association (2012 to date); Council Member of World Federation of Chinese Medicine Societies (2012-2016), etc. Now he is Professor and the head of (1) the Research Unit for Complementary and Integrative Laser Medicine, (2) the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, and (3) the TCM Research Center Graz at the Medical University of Graz. Professor Litscher’s special interests are computer-based High-Tech Acupuncture Research and Neuromonitoring. He has authored over 600 scientific publications and been invited for many lectures internationally. He is Visiting Professor and/or Honorary Professor of eleven universities and institutions in China.

Editor-in-Chief of Advances in Environmental and Engineering Research

Suni Zed Rengel earned his B.Sc.(Honours) and M.Sc. degrees from Zagreb University (Croatia), and PhD degree from Louisiana State University (USA). He is full Professor of Soil Science and Plant Nutrition at the University of Western Australia (since 2001). Zed supervised 42 postdoctoral fellows, and 39 PhD, 17 MSc and 46 Honours students, and hosted 66 visiting scientists from all over the world. Zed was awarded 9 prizes, 28 fellowships and awards, 4 Honorary Professorships and 5 Visiting Professorships. He gave 50 invited keynote addresses at international Conferences and presented 322 invited seminars at 78 Universities and Professional Societies in 28 countries. Zed is the author/co-author of 400+ publications in peer-refereed international journals and 46 invited book chapters. He edited 8 books and 6 Journal Special Issues. Zed is co-Editor-in-Chief of Crop & Pasture Science (Australia). His h-index is 66 (Web of Science, all databases).

Editor-in-Chief of Journal of Animal Genetics, Transgenesis and Zoonoses

SuniJuergen A. Richt received his Doctorate in Veterinary Medicine (DVM) from the Ludwig-Maximilians-University Munich and PhD in Virology and Immunology from the Justus-Liebig-University Giessen (1988), both in Germany. Afterwards, he completed three years of postdoctoral/residency studies at The Johns Hopkins University in Baltimore, MD, USA. Next, Dr. Richt returned for eight years to the Justus-Liebig-University Giessen as a junior faculty to establish his own research program. He later served for eight years as a Veterinary Medical Officer at the National Animal Disease Center (USDA-ARS) in Ames, Iowa.

Dr. Richt came to Kansas State University in 2008 as The Regents Distinguished Professor and Kansas Bioscience Eminent Scholar. In 2010, he became Director of the Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), which is working with Principal Investigators in 16 different universities, as well as various industrial partners. His work in veterinary microbiology has focused mainly on the animal-human interface, called “One Health” that links human medicine, veterinary medicine and the environment. Dr. Richt has edited several books, published more than 190 peer-reviewed articles and raised more than $33 million in grants for veterinary research.

Editor-in-Chief of OBM Transplantation


Haval Shirwan is Professor of Child Health and Molecular Microbiology and Immunology at the University of Missouri, Columbia, MO, USA. He conducted his Graduate studies at the University of California in Santa Barbara, CA, and Postdoctoral studies at California Institute of Technology in Pasadena, CA. Dr. Shirwan joined the University of Missouri in 2020 after holding academic appointments at various academic institutions in the United States. His research focuses on the modulation of immune system for the treatment of immune-based diseases with particular focus on type 1 diabetes, transplantation (cell, tissue, and solid organs), and cancer immunoprevention and immunotherapy. He co-pioneered with Esma S. Yolcu the concept of transient and positional display of novel immunological ligands on biologic surfaces as a practical alternative to ectopic gene expression for immunomodulation. He is an inventor on over a dozen of worldwide patents, widely published, organized and lectured at numerous national/international conferences, and member of several national and international societies.

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.